CN116076638A - Preparation method of probiotics fermented waxberry beverage and product thereof - Google Patents
Preparation method of probiotics fermented waxberry beverage and product thereof Download PDFInfo
- Publication number
- CN116076638A CN116076638A CN202211149768.6A CN202211149768A CN116076638A CN 116076638 A CN116076638 A CN 116076638A CN 202211149768 A CN202211149768 A CN 202211149768A CN 116076638 A CN116076638 A CN 116076638A
- Authority
- CN
- China
- Prior art keywords
- waxberry
- strain
- steps
- following
- inoculating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009134 Myrica cerifera Nutrition 0.000 title claims abstract description 74
- 235000007270 Gaultheria hispida Nutrition 0.000 title claims abstract description 72
- 244000269152 Myrica pensylvanica Species 0.000 title claims abstract description 72
- 235000012851 Myrica pensylvanica Nutrition 0.000 title claims abstract description 72
- 239000006041 probiotic Substances 0.000 title claims abstract description 44
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 44
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 45
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 27
- 238000000855 fermentation Methods 0.000 claims abstract description 22
- 230000004151 fermentation Effects 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000000346 sugar Nutrition 0.000 claims abstract description 20
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 14
- 238000011081 inoculation Methods 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 8
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 29
- 230000001954 sterilising effect Effects 0.000 claims description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 21
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 21
- 239000001963 growth medium Substances 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 18
- 230000001580 bacterial effect Effects 0.000 claims description 16
- 238000012258 culturing Methods 0.000 claims description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 230000003321 amplification Effects 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 12
- 239000002609 medium Substances 0.000 claims description 11
- 230000003213 activating effect Effects 0.000 claims description 10
- 230000000529 probiotic effect Effects 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 9
- 239000001888 Peptone Substances 0.000 claims description 8
- 108010080698 Peptones Proteins 0.000 claims description 8
- 229940041514 candida albicans extract Drugs 0.000 claims description 8
- 235000019319 peptone Nutrition 0.000 claims description 8
- 239000012138 yeast extract Substances 0.000 claims description 8
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- 240000001929 Lactobacillus brevis Species 0.000 claims description 4
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 4
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 4
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
- 235000015278 beef Nutrition 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 claims description 2
- 235000019640 taste Nutrition 0.000 abstract description 10
- 239000000796 flavoring agent Substances 0.000 abstract description 7
- 235000019634 flavors Nutrition 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 6
- 238000003860 storage Methods 0.000 abstract description 3
- 230000000050 nutritive effect Effects 0.000 abstract description 2
- 244000024215 Myrica gale Species 0.000 abstract 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 8
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 108010053775 Nisin Proteins 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 239000004309 nisin Substances 0.000 description 5
- 235000010297 nisin Nutrition 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 235000021391 short chain fatty acids Nutrition 0.000 description 4
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000132436 Myrica rubra Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010989 colorectal carcinoma Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- 208000012657 Atopic disease Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 101000890668 Homo sapiens Free fatty acid receptor 2 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000007218 ym medium Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A23L2/44—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/24—Lactobacillus brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention provides a preparation method of a probiotics fermented waxberry beverage and a product thereof, and the preparation method comprises the following steps: step 1, cleaning waxberries, drying in the shade, placing the waxberries in a fermentation barrel, and adding white granulated sugar for soaking for 1-2 weeks to obtain waxberry sugar juice; wherein the mass ratio of the white granulated sugar to the waxberry is 1:1; step 2, adding a proper amount of water into the waxberry sugar juice, and respectively inoculating a saccharomycete liquid A and a saccharomycete liquid B according to 10% of the inoculation amount and 10% of the inoculation amount of the waxberry volume, and inoculating a probiotics liquid according to 10% of the inoculation amount; step 3, fermenting for 15 to 20 days at the temperature of 10 to 38 ℃ to obtain fermentation liquor; and 4, filtering the fermentation liquor to obtain the product. The invention has simpler production flow and lower cost, and the prepared product can generate multi-level aroma and taste, has better flavor and taste, and has the advantages of high nutritive value and long storage period.
Description
[ field of technology ]
The invention relates to a preparation method of a probiotics fermented waxberry beverage and a product thereof.
[ background Art ]
The sugar content of the waxberry flesh is 12-13%, the acid content is 0.5-1.1%, the waxberry flesh is rich in cellulose, mineral elements, vitamins and a certain amount of protein, fat, pectin and 8 amino acids beneficial to human bodies, and the calcium, phosphorus and iron content of fruits is 10 times higher than that of other fruits. Specifically, the nutrient content of the edible part of each 100 g of waxberry is as follows: 83.4-92.0 g of moisture, 28 kcal of heat, 0.8 g of protein, 0.2 g of fat, 5.7 g of carbohydrate, 1 g of dietary fiber, 12-13 g of sugar content of fruit juice, 0.5-1.8 g of acid content, 10 micrograms of thiamine, 50 micrograms of riboflavin, 0.3 milligram of nicotinic acid, 92 micrograms of retinol equivalent, 0.3 micrograms of carotene, 7 micrograms of vitamin A, 9 milligram of vitamin C, 0.81 milligram of vitamin E, 14 milligram of calcium, 10 milligram of magnesium, 1 milligram of iron, 0.72 milligram of manganese, 0.14 milligram of zinc, 20 milligram of copper, 149 milligram of potassium, 8 milligram of phosphorus, 0.7 milligram of sodium and 0.31 milligram of selenium.
The traditional Chinese medicine is as follows: the waxberry has the effects of promoting the production of body fluid to quench thirst, strengthening spleen and stimulating appetite, and can be eaten more without damaging spleen and stomach, and has the effects of detoxifying and dispelling cold. The "Ben Cao gang mu" describes that "Yang Meike quench thirst, harmonize five internal organs, and remove gastrointestinal tract and restlessness and malignant head". Yang Meixing has effects of resolving food stagnation, removing dampness, relieving summer-heat, promoting salivation, relieving cough, promoting digestion, resisting cold, relieving diarrhea, promoting urination, and preventing and treating cholera, and is also called agate in fruit. Because the waxberry has various medicinal values of promoting digestion, resisting cold, relieving summer heat, stopping diarrhea, promoting urination, treating diarrhea, promoting salivation, quenching thirst, clearing intestines and stomach, relieving restlessness anger, and the like, the medical community in China has higher evaluation on the waxberry.
The fructus Myricae Rubrae contains various organic acids and abundant vitamin C, and fresh fruits are not easy to preserve, and can be made into fructus Myricae Rubrae beverage. The manufacturing flow in the market: cleaning fructus Myricae Rubrae, adding 3% salt and water, soaking for 15 min, adding sugar and water (10 Kg Yang Meijia Kg sugar, 1 liter water); then heating to 65 ℃ for stewing for 10 minutes, soaking for 15 hours, and filtering; continuously adding water to adjust the sugar degree to 14-16 Brix, adding citric acid to adjust the acidity to 0.7%, heating to 90 ℃, hot-filling, sterilizing at 90 ℃ for 5 minutes to obtain a finished product, and preserving in a refrigerator. Thus, the existing commercial production methods have the following disadvantages:
1. the production steps are more and the process is complex; 2. because of multiple times of heating, natural enzymes of the waxberries are destroyed; 3. the energy is wasted by multiple times of cooking; 4. food additives, citric acid must be added; the finished product needs to be preserved by a refrigerator, has the defects of troublesome transportation and preservation and high cost, and has short preservation period (preservation and preservation for 1-3 months).
[ invention ]
The invention aims to solve the technical problem of providing a preparation method of a probiotics fermented waxberry beverage and a product thereof, wherein the preparation method has the advantages of simpler production flow, lower cost, multi-level aroma and taste, better flavor and taste, high nutritional value and long storage life.
The invention is realized in the following way:
a preparation method of a probiotics fermented waxberry beverage comprises the following steps:
step 1, cleaning waxberries, drying in the shade, placing the waxberries in a fermentation barrel, and adding white granulated sugar for soaking for 1-2 weeks to obtain waxberry sugar juice; wherein the mass ratio of the white granulated sugar to the waxberry is 1:1;
step 2, adding a proper amount of water into the waxberry sugar juice, and respectively inoculating a saccharomycete liquid A and a saccharomycete liquid B according to 10% of the inoculation amount and 10% of the inoculation amount of the waxberry volume, and inoculating a probiotics liquid according to 10% of the inoculation amount;
step 3, fermenting for 15 to 20 days at the temperature of 10 to 38 ℃ to obtain fermentation liquor;
step 4, filtering the fermentation liquor to obtain a product;
the preparation process of the saccharomycete liquid A comprises the following steps:
(1) Activating the strain: inoculating yeast (Saccharomyces cerevisiae) BCRC20581 into YM Broth, and performing activation culture at 24+ -2deg.C for 24-32h to obtain activated strain;
(2) The strain is amplified once: inoculating the activated strain into a new culture medium YM Broth, and culturing at 24+/-2 ℃ for 10-16 hours to obtain primary amplified bacterial liquid;
(3) Strain secondary amplification: inoculating the primary amplified bacterial liquid into a first culture medium, and culturing for 10-16 hours at 24+/-2 ℃ to obtain a saccharomycete liquid A; in the first medium: 250ml of waxberry sugar juice and 1L of water, wherein the preparation method of the waxberry sugar juice is the same as that of the step 1;
the preparation process of the saccharomycete liquid B comprises the following steps:
(1) Activating the strain: inoculating yeast (Saccharomyces cerevisiae) BCRC21967 into YPD Broth, and performing activation culture at 24+ -2deg.C for 24-32 hr to obtain activated strain;
(2) The strain is amplified once: inoculating the activated strain to a new culture medium YPD Broth, and culturing at 24+/-2 ℃ for 10-16 hours to obtain primary amplifying bacterial liquid;
(3) Strain secondary amplification: inoculating the primary amplified bacterial liquid into a first culture medium, and culturing for 10-16 hours at 24+/-2 ℃ to obtain a saccharomycete liquid B;
the preparation process of the probiotic bacteria liquid comprises the following steps:
(1) Activating the strain: inoculating probiotic strains of Lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus delbrueckii subspecies, lactobacillus reuteri, lactobacillus brevis, lactobacillus casei and Lactobacillus fermentum respectively into a second culture medium, and performing activation culture at 37+ -2deg.C for 36-48 hr to obtain activated strains;
(2) Strain amplification: 7 activated strains are mixed and inoculated into a first culture medium, and are subjected to amplification culture for 18-24 hours at 37+/-2 ℃ to obtain probiotic bacterial liquid.
Further, the method also comprises sterilization, namely filtering the fermentation liquor and then sterilizing to obtain a product; the sterilization method comprises the following steps:
and (3) carrying out instantaneous sterilization on the filtrate at the ultrahigh temperature of 137+/-5 ℃ for 15 seconds, and packaging by utilizing a tetra Pak to obtain a finished product.
Further, the method also comprises sterilization, and the sterilization method comprises the following steps:
sterilizing the filtrate at 85deg.C for 45 min, filling into pop-top can, and sterilizing at 115+ -5deg.C for 15 min.
Further, the mass ratio of the water added in the step 2 to the waxberry is 2:1.
Further, in the medium YM Broth: 3.0g of yeast extract, 3.0g of maltose, 5.0g of peptone, 10.0g of glucose and 1L of water;
the medium YPD Broth: yeast extract 10.0g, maltose 3.0g, peptone 20.0g, glucose 20.0g and water 1L.
Further, in the second medium: protease peptone No. 3 10.0g, beef extract 10.0g, yeast extract 5.0g, glucose 20.0g, tween 80 1.0g, ammonium citrate 2.0g, CH 3 COONa 5.0g,MgSO 4 ·7H 2 O 0.1g,MnSO 4 ·H 2 O 0.05g,K 2 HPO 4 2.0g, 1.0L of water; the pH value is adjusted to 6.2-6.5.
Further, the second culture medium also comprises 15.0 grams of agar powder per liter.
Further, according to the preparation method of the waxberry beverage fermented by the probiotics, the waxberry beverage is prepared.
The invention has the following advantages:
the invention adopts two strains of saccharomycetes BCRC20581 and saccharomycetes BCRC21967 (GRAS strain) to cooperatively adopt seven strains of probiotics to ferment the waxberry beverage, and has the following advantages: contains abundant vitamin B group and various vitamins, and active antioxidant ferment; producing a plurality of amino acids including lysine, isoleucine, phenylalanine, tyrosine, tryptophane; the application of various saccharomycetes can generate multi-level aroma and taste, and has the effect of improving the aroma and the flavor, so that the product has good taste and layering sense.
Meanwhile, ferment, lactic acid, organic acid, short chain fatty acid, oligosaccharide and prebiotics can be produced, and ferment is digested; can produce natural bacteriostasis, such as reuterin and nisin, inhibit bad bacteria, and promote shelf life (1-5 years under sterilization condition and 10-15 years under non-sterilization condition); wherein Lactobacillus acidophilus and Lactobacillus reuteri inhibit helicobacter pylori; the total polyphenol and total flavonoid content is improved, and more nutrition and health care ingredients are provided; maintaining normal intestinal bacterial phase of human body, preventing gastrointestinal tract diseases, improving large intestine dysphoria syndrome symptoms, and preventing colitis; has immunoregulatory effect: alleviating food allergy, improving symptoms of atopic disease, and preventing allergy of children; has metabolism function: reducing occurrence probability of colon cancer, relieving lactose intolerance, reducing cholesterol and lowering blood pressure.
In a word, the probiotics fermented red bayberry beverage produced by the invention has the bacteriostasis and antibacterial capability protection of natural lactobacillus bacteriocin, can be permanently stored without sterilization treatment, and can retain live bacteria and ferment; can also be sterilized, and can be stored for 1-5 years without affecting flavor and taste. The two yeasts and seven probiotics used in the invention are GRAS strains authenticated by WHO, and meet the food safety requirement.
[ description of the drawings ]
The invention will be further described with reference to examples of embodiments with reference to the accompanying drawings.
Fig. 1 is a preparation flow chart of a preparation method of the probiotics fermented waxberry beverage.
[ detailed description ] of the invention
The technical solution of the present invention will be clearly and completely described below with reference to fig. 1 and the detailed description. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention. The specific conditions are not noted in the examples and are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
The invention relates to a preparation method of a probiotics fermented waxberry beverage, which comprises the following steps:
step 1, cleaning waxberries, drying in the shade, placing the waxberries in a fermentation barrel, and adding white granulated sugar for soaking for 1-2 weeks to obtain waxberry sugar juice; wherein the mass ratio of the white granulated sugar to the waxberry is 1:1;
step 2, adding a proper amount of water into the waxberry sugar juice, wherein the mass ratio of the added water to the waxberry is 2:1; inoculating a saccharomycete liquid A and a saccharomycete liquid B according to 10% of the inoculation amount and 10% of the inoculation amount of the volume of the waxberry respectively, and inoculating a probiotics liquid according to 10% of the inoculation amount;
step 3, fermenting for 15 to 20 days at the temperature of 10 to 38 ℃ to obtain fermentation liquor;
step 4, filtering the fermentation liquor to obtain a product;
the preparation process of the saccharomycete liquid A comprises the following steps:
(1) Activating the strain: inoculating yeast (Saccharomyces cerevisiae) BCRC20581 into YM Broth, and performing activation culture at 24+ -2deg.C for 24-32h to obtain activated strain;
(2) The strain is amplified once: inoculating the activated strain into a new culture medium YM Broth, and culturing at 24+/-2 ℃ for 10-16 hours to obtain primary amplified bacterial liquid;
(3) Strain secondary amplification: inoculating the primary amplified bacterial liquid into a first culture medium, and culturing for 10-16 hours at 24+/-2 ℃ to obtain a saccharomycete liquid A; in the first medium: 250ml of waxberry sugar juice and 1L of water, wherein the preparation method of the waxberry sugar juice is the same as that of the step 1;
the preparation process of the saccharomycete liquid B comprises the following steps:
(1) Activating the strain: inoculating yeast (Saccharomyces cerevisiae) BCRC21967 into YPD Broth, and performing activation culture at 24+ -2deg.C for 24-32 hr to obtain activated strain;
(2) The strain is amplified once: inoculating the activated strain to a new culture medium YPD Broth, and culturing at 24+/-2 ℃ for 10-16 hours to obtain primary amplifying bacterial liquid;
(3) Strain secondary amplification: inoculating the primary amplified bacterial liquid into a first culture medium, and culturing for 10-16 hours at 24+/-2 ℃ to obtain a saccharomycete liquid B;
the preparation process of the probiotic bacteria liquid comprises the following steps:
(1) Activating the strain: inoculating probiotic strains of Lactobacillus acidophilus (Lactobacillus acidophilus), lactobacillus bulgaricus (Lactobacillus bulgaricus), lactobacillus delbrueckii subspecies (Lactobacillus delbrueckii subsp. Lactis), lactobacillus reuteri (Lactobacillus reuteri), lactobacillus brevis (Lactobacillus brevis), lactobacillus casei (Lactobacillus casei) and Lactobacillus fermentum (Lactobacillus fermentum) respectively in a second culture medium, and performing activation culture at 37+ -2deg.C for 36-48h to obtain activated strains;
(2) Strain amplification: 7 activated strains are mixed and inoculated into a first culture medium, and are subjected to amplification culture for 18-24 hours at 37+/-2 ℃ to obtain probiotic bacterial liquid.
The method also comprises sterilizing, namely filtering the fermentation liquor and then sterilizing to obtain a product; the sterilization method comprises the following steps: and (3) carrying out instantaneous sterilization on the filtrate at the ultrahigh temperature of 137+/-5 ℃ for 15 seconds, and packaging by utilizing a tetra Pak to obtain a finished product. Or sterilizing the filtrate at 85deg.C for 45 min, filling into pop-top can, and sterilizing at 115+ -5deg.C for 15 min.
The invention also relates to a preparation method of the probiotics fermented waxberry beverage, and the prepared waxberry beverage.
Table 1 below shows the components of YM medium for culturing the yeast liquid A:
TABLE 1
Medium YM fraction | Content of |
Yeast extract (Yeast extract) | 3.0g |
Maltose (Malt extract) | 3.0g |
Peptone (Peptone) | 5.0g |
Glucose (Dextrose) | 10.0g |
Distilled water (Distilled water) | 1L |
The YPD composition of the medium for culturing the yeast liquid B shown in Table 2 below:
TABLE 2
The following table 3 shows the second medium composition for the culture of probiotics liquid, the pH value is 6.2-6.5, and 15.0 g of agar powder per liter can be added according to the requirement:
TABLE 3 Table 3
The waxberry beverage produced by utilizing probiotics fermentation contains abundant short-chain fatty acids (SCFA, wherein each 100ml of waxberry beverage contains 0.4-1.2 g of short-chain fatty acids): short chain fatty acid is a readily volatile fatty acid which is produced by fermentation of indigestible foods such as dietary fiber, resistant starch, etc. by lactic acid bacteria or yeasts in the mammalian intestinal tract. The short-chain fatty acid is mainly acetic acid, propionic acid and butyric acid, and accounts for 83% of the short-chain fatty acid in intestinal tracts. The generated short chain fatty acid can be a source for utilizing intestinal probiotics and also can enter the blood circulation of the human body, thereby being an energy source for providing the human body and regulating the functions of the human body. The short chain fatty acid can provide energy for large intestine cells in intestinal tracts, promote differentiation of the intestinal cells, maintain healthy intestinal mucosa, promote intestinal peristalsis, inhibit harmful bacteria, promote growth of beneficial bacteria and the like. For the whole health, the short chain fatty acid has the effects of promoting the production of serotonin, regulating the immune cells of the body part to achieve the effects of anti-inflammatory, anti-tumor and antibacterial. Short chain fatty acids are also closely related to the cells of the large intestine. It has been found that short chain fatty acids can achieve anticancer effects by regulating intracellular activities and cell surface proteins, and can reactivate GPR43 protein on carcinoma of large intestine cells, thereby inhibiting tumor growth and inducing cancer cell death, and helping to reduce risk of developing carcinoma of large intestine.
In the method, the waxberry is fermented by probiotics to increase the contents of ferment, flavonoid (the content is 1-2 times of the waxberry) and polyphenol (the content is 2-3 times of the waxberry), so that the free radical resistance and the oxidation resistance of the waxberry are improved. The main working contents of ferment in human body are: the main effects of digestion, absorption and catabolism are to increase the nutrition absorption speed and the decomposition efficiency, so that the digestion process is smoother, and the nutrition-absorbing agent is an essential substance for maintaining physiological functions of human beings. The ferment is supplemented, so that the digestion process is smoother, and the health care of the body is facilitated. Flavonoids are water-soluble substances with antioxidant, antiviral and antiinflammatory effects. The traditional Chinese medicine considers that the component can nourish qi and blood; enhancing immunity and resisting aging. Also has the effect of activating blood; can promote microcirculation, blood stasis, and improve cardiovascular system. And has effects of clearing heat and detoxicating, and resisting virus and inflammation. Polyphenols help to lower blood glucose levels, help to stimulate insulin secretion, improve glucose tolerance and increase insulin sensitivity, and reduce the risk of type 2 diabetes. Polyphenols may also improve heart health because of their antioxidant properties, which helps reduce chronic inflammation. Polyphenols reduce the risk of thrombosis when platelets circulating in the blood begin to aggregate together. Excessive platelet aggregation may lead to thrombosis, which may negatively impact health, including deep vein thrombosis, stroke, and pulmonary embolism. Polyphenols help reduce platelet aggregation.
The invention takes fresh fruits of the waxberries as raw materials, utilizes probiotics and yeast fermentation, completely retains the nutritive value of the waxberries, and has the following advantages:
(1) No preservative is added: the probiotics are utilized to produce the reuterin and nisin (bacteriostasis/nisin) which are used for killing harmful bacteria, the natural red bayberry has lasting fragrance and gorgeous color, and no pigment or essence is added; has good taste and good flavor, and contains natural beneficial components of fructus Myricae Rubrae. Because the microbial fermentation is used for producing more substances (amino acid, polyphenol, like flavone, vitamin E, short fatty acid, organic acid and ferment) beneficial to human bodies, the additional effect of extending the waxberry is improved. The deep processing of agricultural products is improved, and the beverage with low price and good health is provided.
(2) The yeast adopted by the invention is single-cell eukaryote, and belongs to facultative anaerobic organisms. The secondary metabolic pathway is determined to be aerobic respiration or fermentation according to the oxygen concentration in the environment. Saccharomycetes use ATP produced by glycolysis to ferment sugars, producing alcohol and carbon dioxide, with the following reaction formula:
C6H12O6→2C2H5OH+2CO2
the yeast has a mechanism called glucose inhibition, which makes the yeast only use glucose when the glucose exists; in the case of glucose alone, when oxygen is not supplied, the yeast will reduce the pyruvic acid to produce alcohol and carbon dioxide for survival.
The patent selects saccharomycetes for improving the fragrance of fruits to ferment, and utilizes probiotics (lactobacillus reuteri) capable of producing bacterionase, namely the reuteri, to control the saccharomycetes to ferment without producing wine. In addition, the probiotics are selected so that the product has the following characteristics: the method has the advantages that (1) the flavor is excellent, (2) Lactobacillus bacteriocins, namely, reuterin and nisin (3) Lactobacillus which are absolute homotype fermentation can be generated, (4) the waxberry is used as a raw material, the flavor and the taste are better through the fermentation of saccharomycetes and probiotics, and the waxberry has natural organic acid and organic acid generated by microorganism metabolism, so that the sweet and sour taste is obtained, and the taste is good. The lactobacillus (lactic acid/nisin) produced by probiotics protects the waxberry beverage, prolongs the storage period to 1-5 years, and achieves the beverage with good palatability without adding essence, spice and preservative.
While specific embodiments of the invention have been described above, it will be appreciated by those skilled in the art that the specific embodiments described are illustrative only and not intended to limit the scope of the invention, and that equivalent modifications and variations of the invention in light of the spirit of the invention will be covered by the claims of the present invention.
Claims (8)
1. A preparation method of a probiotics fermented waxberry beverage is characterized by comprising the following steps of: the method comprises the following steps:
step 1, cleaning waxberries, drying in the shade, placing the waxberries in a fermentation barrel, and adding white granulated sugar for soaking for 1-2 weeks to obtain waxberry sugar juice; wherein the mass ratio of the white granulated sugar to the waxberry is 1:1;
step 2, adding a proper amount of water into the waxberry sugar juice, and respectively inoculating a saccharomycete liquid A and a saccharomycete liquid B according to 10% of the inoculation amount and 10% of the inoculation amount of the waxberry volume, and inoculating a probiotics liquid according to 10% of the inoculation amount;
step 3, fermenting for 15 to 20 days at the temperature of 10 to 38 ℃ to obtain fermentation liquor;
step 4, filtering the fermentation liquor to obtain a product;
the preparation process of the saccharomycete liquid A comprises the following steps:
(1) Activating the strain: inoculating yeast (Saccharomyces cerevisiae) BCRC20581 into YM Broth, and performing activation culture at 24+ -2deg.C for 24-32h to obtain activated strain;
(2) The strain is amplified once: inoculating the activated strain into a new culture medium YM Broth, and culturing at 24+/-2 ℃ for 10-16 hours to obtain primary amplified bacterial liquid;
(3) Strain secondary amplification: inoculating the primary amplified bacterial liquid into a first culture medium, and culturing for 10-16 hours at 24+/-2 ℃ to obtain a saccharomycete liquid A; in the first medium: 250ml of waxberry sugar juice and 1L of water, wherein the preparation method of the waxberry sugar juice is the same as that of the step 1;
the preparation process of the saccharomycete liquid B comprises the following steps:
(1) Activating the strain: inoculating yeast (Saccharomyces cerevisiae) BCRC21967 into YPD Broth, and performing activation culture at 24+ -2deg.C for 24-32 hr to obtain activated strain;
(2) The strain is amplified once: inoculating the activated strain to a new culture medium YPD Broth, and culturing at 24+/-2 ℃ for 10-16 hours to obtain primary amplifying bacterial liquid;
(3) Strain secondary amplification: inoculating the primary amplified bacterial liquid into a first culture medium, and culturing for 10-16 hours at 24+/-2 ℃ to obtain a saccharomycete liquid B;
the preparation process of the probiotic bacteria liquid comprises the following steps:
(1) Activating the strain: inoculating probiotic strains of Lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus delbrueckii subspecies, lactobacillus reuteri, lactobacillus brevis, lactobacillus casei and Lactobacillus fermentum respectively into a second culture medium, and performing activation culture at 37+ -2deg.C for 36-48 hr to obtain activated strains;
(2) Strain amplification: 7 activated strains are mixed and inoculated into a first culture medium, and are subjected to amplification culture for 18-24 hours at 37+/-2 ℃ to obtain probiotic bacterial liquid.
2. The method for preparing the probiotics fermented waxberry beverage according to claim 1, wherein the method comprises the following steps: the method also comprises sterilizing, namely filtering the fermentation liquor and then sterilizing to obtain a product; the sterilization method comprises the following steps:
and (3) carrying out instantaneous sterilization on the filtrate at the ultrahigh temperature of 137+/-5 ℃ for 15 seconds, and packaging by utilizing a tetra Pak to obtain a finished product.
3. The method for preparing the probiotics fermented waxberry beverage according to claim 1, wherein the method comprises the following steps: the method further comprises sterilization, and the sterilization method comprises the following steps:
sterilizing the filtrate at 85deg.C for 45 min, filling into pop-top can, and sterilizing at 115+ -5deg.C for 15 min.
4. The method for preparing the probiotics fermented waxberry beverage according to claim 1, wherein the method comprises the following steps: and (2) the mass ratio of the water added in the step (2) to the waxberry is 2:1.
5. The method for preparing the probiotics fermented waxberry beverage according to claim 1, wherein the method comprises the following steps: the medium YM Broth: 3.0g of yeast extract, 3.0g of maltose, 5.0g of peptone, 10.0g of glucose and 1L of water;
the medium YPD Broth: yeast extract 10.0g, maltose 3.0g, peptone 20.0g, glucose 20.0g and water 1L.
6. The method for preparing the probiotics fermented waxberry beverage according to claim 1, wherein the method comprises the following steps: in the second medium: protease peptone No. 3 10.0g, beef extract 10.0g, yeast extract 5.0g, glucose 20.0g, tween 80 1.0g, ammonium citrate 2.0g, CH 3 COONa 5.0g,MgSO 4 ·7H 2 O 0.1g,MnSO 4 ·H 2 O 0.05g,K 2 HPO 4 2.0g, 1.0L of water; the pH value is adjusted to 6.2-6.5.
7. The method for preparing the probiotics fermented waxberry beverage according to claim 6, wherein the method comprises the following steps: the second culture medium also comprises 15.0 g of agar powder per liter.
8. A method for preparing a probiotic fermented bayberry beverage according to any one of claims 1-7, the bayberry beverage prepared thereby.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211149768.6A CN116076638A (en) | 2022-09-21 | 2022-09-21 | Preparation method of probiotics fermented waxberry beverage and product thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211149768.6A CN116076638A (en) | 2022-09-21 | 2022-09-21 | Preparation method of probiotics fermented waxberry beverage and product thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116076638A true CN116076638A (en) | 2023-05-09 |
Family
ID=86212573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211149768.6A Pending CN116076638A (en) | 2022-09-21 | 2022-09-21 | Preparation method of probiotics fermented waxberry beverage and product thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116076638A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101092593A (en) * | 2006-06-21 | 2007-12-26 | 郑建玮 | Method for preparing red wine of mulberry |
US20130295226A1 (en) * | 2011-01-21 | 2013-11-07 | Chr. Hansen A/S | Probiotics in fruit beverages |
US20130302454A1 (en) * | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution Llc. | Method for preparing fermentation broth of fruits and vegetables |
CN104939073A (en) * | 2015-05-22 | 2015-09-30 | 杜雪梅 | Waxberry ferment stock solution and preparation method thereof |
CN107821898A (en) * | 2017-12-11 | 2018-03-23 | 嘉兴佳康丽生物科技有限公司 | A kind of active probiotic pectase beverage and preparation method thereof |
CN110024931A (en) * | 2019-05-07 | 2019-07-19 | 贵阳学院 | A kind of preparation method of red bayberry fermented beverage |
CN111345417A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of fig enzyme beverage |
CN111345416A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of mulberry enzyme beverage |
-
2022
- 2022-09-21 CN CN202211149768.6A patent/CN116076638A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101092593A (en) * | 2006-06-21 | 2007-12-26 | 郑建玮 | Method for preparing red wine of mulberry |
US20130295226A1 (en) * | 2011-01-21 | 2013-11-07 | Chr. Hansen A/S | Probiotics in fruit beverages |
US20130302454A1 (en) * | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution Llc. | Method for preparing fermentation broth of fruits and vegetables |
CN104939073A (en) * | 2015-05-22 | 2015-09-30 | 杜雪梅 | Waxberry ferment stock solution and preparation method thereof |
CN107821898A (en) * | 2017-12-11 | 2018-03-23 | 嘉兴佳康丽生物科技有限公司 | A kind of active probiotic pectase beverage and preparation method thereof |
CN110024931A (en) * | 2019-05-07 | 2019-07-19 | 贵阳学院 | A kind of preparation method of red bayberry fermented beverage |
CN111345417A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of fig enzyme beverage |
CN111345416A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of mulberry enzyme beverage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105249100B (en) | The production method of fermented fruits and vegetables juice and fermented glutinous rice beverage with compound functions | |
CN107568537A (en) | A kind of compound microorganism ferments beverage containing anthocyanidin and preparation method thereof | |
CN1911118B (en) | Kefir mushroom freeze-dried powder, production method and use thereof | |
CN104106785A (en) | Preparation method of pepper pickle fermented by composite lactobacillus | |
CN111066989A (en) | Compound beverage and preparation method thereof | |
Chaudhary et al. | Prospects of Indian traditional fermented food as functional foods | |
CN110169545A (en) | A method of fermentation duck is prepared using lactic acid bacteria | |
CN105029252A (en) | Rapid production method of lactic acid bacteria fermented soya beans capable of dissolving fibrous protein | |
CN105852011A (en) | Method for preparing lotus seed functional fermented food | |
KR20230037529A (en) | Preparation method of ingredients powder fermented by lactic acid bacteria | |
CN111418746A (en) | Pumpkin and apple compound fermented beverage and preparation method and application thereof | |
CN104382129A (en) | Beverage prepared from sweet corn and black tea fungus | |
CN104273613A (en) | Mango tea fungus drink | |
CN112273648B (en) | Moringa seed enzyme and biological fermentation method thereof | |
CN103039845A (en) | Fermented black corn food and preparation method thereof | |
CN113208077A (en) | Preparation method of probiotic medlar vinegar jelly | |
CN108887680A (en) | A kind of efficient small molecule nutritional preparation and preparation method thereof for promoting intestinal beneficial bacterium proliferation | |
CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
CN109497499B (en) | Mulberry soy sauce | |
CN113693205A (en) | Healthy flavored soybean milk formula and production process thereof | |
CN105982108B (en) | Carrot juice beverage and preparation method thereof | |
CN106617095A (en) | Donkey-hide gelatin probiotics oral liquid and preparation method thereof | |
CN116076638A (en) | Preparation method of probiotics fermented waxberry beverage and product thereof | |
CN115812885A (en) | Preparation process for loquat and snow pear juice by fermenting metazoan and composite probiotics | |
CN110692886A (en) | Preparation method of banana and needle mushroom beverage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |